cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the united states成本效益模型比较奥氮平与其他口服非典型抗精神病药物治疗精神分裂症在美国.pdfVIP

  • 4
  • 0
  • 约15.31万字
  • 约 22页
  • 2017-09-06 发布于上海
  • 举报

cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the united states成本效益模型比较奥氮平与其他口服非典型抗精神病药物治疗精神分裂症在美国.pdf

cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the united states成本效益模型比较奥氮平与其他口服非典型抗精神病药物治疗精神分裂症在美国

Cost Effectiveness and Resource Allocation BioMed Central Research Open Access Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States 1 2 1

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档